Kahira Pharmaceuticals is an Egypt-based company involved in the manufacture and trade of pharmaceutical products for human and veterinary use.
Rameda, a leading Egyptian pharmaceutical company, has signed several partnership agreements with various agents in different countries.
With investments, innovation, and a focus on both traditional and alternative medicine, Egypt is poised to maintain its leadership in pharmaceuticals.
Despite the country’s strategic reserve of pharmaceuticals, some Egyptians, especially those with chronic diseases, are still struggling.
Egypt's strategic stock of medicines is enough to cater to domestic consumption for a period of 6 to 12 months.
Africa advanced efforts to develop an independent drug industry after Rwanda agreed to host the African Pharmaceutical Technology Foundation (APTF) .
Elba added that the plan involves constructing a new factory in Egypt with an initial investment of over EGP 1 billion.
Valu and GSK aim to create a more inclusive and equitable healthcare ecosystem, aligning with their shared vision of advancing public health.
The Saudi Batterjee Holding Group has unveiled its plans to acquire a pharmaceutical company listed on the Egyptian Exchange (EGX) within 6 months.
The company’s earnings before interest, taxes, and depreciation (EBITDA) increased by 101% during the first nine months of 2023.
The move comes as part of Jamjoom’s expansion plan to open new investment channels.
GNP had the pleasure of welcoming the Autorité Congolaise de Réglementation Pharmaceutique (ACOREP)
American conglomerate Cencora, formerly AmerisourceBergen, is reportedly offering 30 percent of its total 50 percent of the UCP to Tamer Healthcare.
The Egyptian Authority for Unified Purchasing (UPA) is supplying Zambia with a total value of $24 million of pharmaceutical supplies.
Egyptian medical city GYPTO Pharma and a group of local companies on Monday signed EGP 4 billion ($129.44 million) worth of contracts.
This joint venture between Grifols and NSPO is part of a larger plan to build and operate 20 plasma donation centres in Egypt.
Egypt emerges as a global leader in herbal medicine exports, ranking fourth worldwide in 2022. Discover the trend towards alternative medicine, driven by affordability and accessibility.
The first phase of the project, worth some USD 101 mn, will see Acdima set up production lines for 21 pharma raw materials starting 2026.
The firm earned EGP 119.213 million in net profits in FY 2022/2023, up from EGP 89.672 million in the previous FY.
Egypt's ascent to the top of the MENA pharmaceutical market in 2023 is a testament to its strategic advantages and thriving domestic industry.